Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 12/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL990270 | 1.00 | GRM5 (0.43) | GRM5L3MBTL1NPC1RAB9ACNR2 | |
| SCHEMBL991609 | 0.90 | GRM5 (0.46) | GRM5 | |
| SCHEMBL3378678 | 0.87 | GRM5 (0.44) | GRM5L3MBTL1NPC1RAB9A | |
| SCHEMBL3373475 | 0.87 | GRM5 (0.44) | GRM5L3MBTL1NPC1RAB9A | |
| SCHEMBL990862 | 0.84 | NPC1 (0.45) | GRM5L3MBTL1NPC1RAB9ACNR2 | |
| SCHEMBL992650 | 0.84 | NPC1 (0.45) | GRM5L3MBTL1NPC1RAB9ACNR2 | |
| SCHEMBL990340 | 0.83 | L3MBTL1 (0.59) | GRM5L3MBTL1NPC1RAB9AMEN1 | |
| SCHEMBL990196 | 0.82 | CNR2 (0.48) | GRM5L3MBTL1NPC1RAB9ACNR2 | |
| SCHEMBL992298 | 0.82 | CNR2 (0.48) | GRM5L3MBTL1NPC1RAB9ACNR2 | |
| SCHEMBL990125 | 0.81 | GRM5 (0.57) | GRM5L3MBTL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2272509-A1 | New Uses of metabotropic glutamate receptors | Novartis AG (CH) | 2011-01-12 | — | — | EP | disclosed |